Matt Shaw

Matt Shaw,

Clinical Research Coordinator, III

Department: Department of Emergency Medicine
Business Phone: (352) 733-1474

About Matt Shaw

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0003-1845-9445

Publications

2023
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
The New England journal of medicine. 388(6):499-510 [DOI] 10.1056/NEJMoa2212663. [PMID] 36688507.
2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
The Lancet. Respiratory medicine. 10(9):888-899 [DOI] 10.1016/S2213-2600(22)00088-1. [PMID] 35617986.
2021
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine. 384(9):795-807 [DOI] 10.1056/NEJMoa2031994. [PMID] 33306283.
2021
Effectiveness and Reach of the Primary Palliative Care for Emergency Medicine (PRIM-ER) Pilot Study: a Qualitative Analysis.
Journal of general internal medicine. 36(2):296-304 [DOI] 10.1007/s11606-020-06302-2. [PMID] 33111240.
2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
The Lancet. Respiratory medicine. 9(12):1365-1376 [DOI] 10.1016/S2213-2600(21)00384-2. [PMID] 34672949.
2021
The ARREST Pneumonia Clinical Trial. Rationale and Design.
Annals of the American Thoracic Society. 18(4):698-708 [DOI] 10.1513/AnnalsATS.202009-1115SD. [PMID] 33493423.

Contact Details

Phones:
Business:
(352) 733-1474
Addresses:
Business Mailing:
PO Box 100186
GAINESVILLE FL 32610
Business Street:
1329 SW 16TH ST STE 5270
GAINESVILLE FL 32608